| Title |
Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice
|
|---|---|
| Published in |
Psychopharmacology, March 2014
|
| DOI | 10.1007/s00213-014-3478-5 |
| Pubmed ID | |
| Authors |
David Cheng, Jac Kee Low, Warren Logge, Brett Garner, Tim Karl |
| Abstract |
Patients suffering from Alzheimer's disease (AD) exhibit a decline in cognitive abilities including an inability to recognise familiar faces. Hallmark pathological changes in AD include the aggregation of amyloid-β (Aβ), tau protein hyperphosphorylation as well as pronounced neurodegeneration, neuroinflammation, neurotoxicity and oxidative damage. |
X Demographics
The data shown below were collected from the profiles of 26 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 11 | 42% |
| United Kingdom | 2 | 8% |
| Canada | 2 | 8% |
| Poland | 1 | 4% |
| Chile | 1 | 4% |
| Unknown | 9 | 35% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 23 | 88% |
| Practitioners (doctors, other healthcare professionals) | 2 | 8% |
| Science communicators (journalists, bloggers, editors) | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 238 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 234 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 44 | 18% |
| Student > Ph. D. Student | 41 | 17% |
| Student > Master | 35 | 15% |
| Researcher | 25 | 11% |
| Professor > Associate Professor | 10 | 4% |
| Other | 21 | 9% |
| Unknown | 62 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Neuroscience | 43 | 18% |
| Agricultural and Biological Sciences | 26 | 11% |
| Medicine and Dentistry | 25 | 11% |
| Psychology | 20 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 19 | 8% |
| Other | 33 | 14% |
| Unknown | 72 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 66. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 June 2023.
All research outputs
#637,100
of 25,163,621 outputs
Outputs from Psychopharmacology
#175
of 5,636 outputs
Outputs of similar age
#5,815
of 228,834 outputs
Outputs of similar age from Psychopharmacology
#4
of 67 outputs
Altmetric has tracked 25,163,621 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,636 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.5. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 228,834 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 67 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.